Baxter International Inc. (BAX)

67.05
NYSE : Health Technology
Prev Close 66.98
Day Low/High 66.75 / 67.40
52 Wk Low/High 52.59 / 72.58
Avg Volume 3.17M
Exchange NYSE
Shares Outstanding 537.81M
Market Cap 36.02B
EPS 1.30
P/E Ratio 51.52
Div & Yield 0.64 (0.95%)

Latest News

Mallinckrodt Completes Sale Of RECOTHROM® And PREVELEAK® To Baxter

Mallinckrodt Completes Sale Of RECOTHROM® And PREVELEAK® To Baxter

-- Transaction supports Mallinckrodt's transformation to an innovation-driven specialty pharmaceutical growth company focused on improving outcomes for patients with severe and critical conditions --

Baxter Completes Acquisition Of RECOTHROM And PREVELEAK To Broaden Surgical Hemostat And Sealant Portfolio

Baxter Completes Acquisition Of RECOTHROM And PREVELEAK To Broaden Surgical Hemostat And Sealant Portfolio

Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its previously announced acquisition of two hemostat and sealant...

Why Value Investor Benjamin Graham Remains Relevant Today

Why Value Investor Benjamin Graham Remains Relevant Today

I still also use Graham-inspired stock screens, including one based on his 'stocks for the defensive investor' methodology.

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Barclays Global Healthcare Conference on Tuesday, March 13, 2018, in Miami, Fla.

Baxter To Present At The Raymond James & Associates 39th Annual Institutional Investors Conference

Baxter To Present At The Raymond James & Associates 39th Annual Institutional Investors Conference

Baxter International Inc. (NYSE: BAX) will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla.

Baxter Reports 2017 Fourth-Quarter And Full-Year Results

Baxter Reports 2017 Fourth-Quarter And Full-Year Results

Baxter International Inc. (NYSE:BAX) today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.

Baxter To Present At The RBC Capital Markets 2018 Global Healthcare Conference

Baxter To Present At The RBC Capital Markets 2018 Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018, in New York.

Baxter Announces U.S. FDA Approval Of Ready-to-Use Cardiovascular Medication Bivalirudin

Baxter Announces U.S. FDA Approval Of Ready-to-Use Cardiovascular Medication Bivalirudin

Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.

Baxter To Present At The 7th Annual Leerink Partners Global Healthcare Conference

Baxter To Present At The 7th Annual Leerink Partners Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the 7th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 14, 2018, in New York.

Baxter Launches Arisure Closed System Transfer Device To Help Prevent Hazardous Drug Exposure And Maintain Medication Sterility

Baxter Launches Arisure Closed System Transfer Device To Help Prevent Hazardous Drug Exposure And Maintain Medication Sterility

Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced a distribution agreement for the U.

Baxter To Host Fourth Quarter 2017 Financial Results Conference Call For Investors

Baxter To Host Fourth Quarter 2017 Financial Results Conference Call For Investors

Baxter International (NYSE: BAX), will host a conference call to discuss its fourth quarter 2017 financial results on Thursday, February 1, 2018, at 7:30 a.

Baxter Announces Agreement To Broaden Portfolio Of Innovative Surgical Products

Baxter Announces Agreement To Broaden Portfolio Of Innovative Surgical Products

Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced an agreement to acquire two hemostat and sealant products from Mallinckrodt plc:...

Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

-- Sale of hemostasis products reflects further refinement of MNK portfolio and strategy --

Should You Dump Johnson & Johnson for Baxter and Abbott?

Should You Dump Johnson & Johnson for Baxter and Abbott?

While Johnson & Johnson is far from a bad company, there may be more upside in Abbott Laboratories and Baxter International.

Baxter To Present At The 36th Annual J.P. Morgan Healthcare Conference

Baxter To Present At The 36th Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the 36th Annual J.

Baxter International Foundation And Direct Relief Mobile Health Program Connects 23,000 People To Critical Health Services In First Year

Baxter International Foundation And Direct Relief Mobile Health Program Connects 23,000 People To Critical Health Services In First Year

Driving Your Health (Manejando tu Salud), a mobile health program supported by Baxter International Foundation and the global humanitarian organization Direct Relief, has provided direct access to important health services...

Baxter To Present At The BMO Capital Markets Prescriptions For Success Healthcare Conference

Baxter To Present At The BMO Capital Markets Prescriptions For Success Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017, in New York at 11:30 a.

Baxter Recognized As Military Friendly Employer For Commitment To Veterans

Baxter Recognized As Military Friendly Employer For Commitment To Veterans

Baxter International Inc. (NYSE: BAX) announced today that it has been recognized as a Military Friendly ® Employer for 2018 by Victory Media.

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.

Baxter To Present At The Piper Jaffray Healthcare Conference

Baxter To Present At The Piper Jaffray Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017, in New York.

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX) announced today that its Board of Directors has declared a quarterly dividend of $0.

Baxter Receives Perfect Score From Human Rights Campaign Foundation For Best Place To Work For LGBTQ Equality

Baxter Receives Perfect Score From Human Rights Campaign Foundation For Best Place To Work For LGBTQ Equality

Baxter International Inc. (NYSE: BAX) announced today that it has earned a top score of 100 percent on the Human Rights Campaign Foundation's 2018 Corporate Equality Index (CEI).

Baxter Presents Data On The Role Of SHARESOURCE Telehealth Platform In Helping The Clinical Management Of Peritoneal Dialysis Patients

Baxter Presents Data On The Role Of SHARESOURCE Telehealth Platform In Helping The Clinical Management Of Peritoneal Dialysis Patients

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, presented new data on SHARESOURCE, the company's remote patient management platform, indicating the potential value of this telehealth platform to...

Baxter Highlights New Clinical Data Showing HDx Enabled By THERANOVA Removes Mid-Sized Uremic Toxins During Dialysis

Baxter Highlights New Clinical Data Showing HDx Enabled By THERANOVA Removes Mid-Sized Uremic Toxins During Dialysis

Baxter International Inc., a global innovator in renal care, highlighted new data on its expanded hemodialysis (HDx) therapy enabled by the THERANOVA dialyzer, adding to the growing body of evidence demonstrating the novel...

Baxter Supports 27 Abstract Presentations At ASN Kidney Week To Advance Scientific Exchange Focused On New Standards Of Renal Care

Baxter Supports 27 Abstract Presentations At ASN Kidney Week To Advance Scientific Exchange Focused On New Standards Of Renal Care

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced the presentation of 27 abstracts at the American Association of Nephrology (ASN) Kidney Week, Oct.

Baxter Launches PD-First Program For Employees And Families

Baxter Launches PD-First Program For Employees And Families

Baxter International Inc. (NYSE:BAX), a global medical products company, announced a new PD-first program for its employees and family members aimed at improving education and awareness of dialysis treatment options,...

Puerto Rico's Once-Bustling Healthcare Industry Remains In Disarray

Puerto Rico's Once-Bustling Healthcare Industry Remains In Disarray

More than a month after Hurricane Maria devastated Puerto Rico, more than 80% of the U.S. territory is without power.

TheStreet Quant Rating: B (Buy)